Investment Rating - The report does not explicitly state an investment rating for Tencent Holdings [2] Core Insights - Tencent is undergoing a strategic transformation driven by AI, with a focus on organizational restructuring and cloud business profitability milestones. The CEO, Ma Huateng, emphasized that AI is the only area worth significant investment at this time, and the company has successfully transitioned to self-developed products [2][3] - The launch of the "Yuanbao" project marks a significant step in Tencent's "AI + social" strategy, aiming to enhance user engagement through integrated social features and AI capabilities. Tencent plans to invest 1 billion yuan to promote this initiative, targeting exponential growth in AI user numbers during the 2026 Spring Festival [3] - Tencent's gaming business is thriving, with overseas revenue exceeding 10 billion USD, accounting for approximately 30% of total gaming revenue. The company has regained confidence in its core gaming operations, providing stable cash flow and growth potential [4] - In response to challenges in the short drama sector, Tencent Video is shifting towards an "advertising-driven" model while maintaining high-quality long-form content. The company has already produced several successful short drama projects and is exploring new ways to balance content depth and traffic efficiency [5] Summary by Sections Strategic Overview - Tencent's current strategy focuses on AI-driven organizational restructuring and achieving profitability in its cloud business, with a clear commitment to investing in AI technologies [2] AI Initiatives - The "Yuanbao" project represents a critical advancement in Tencent's AI and social strategy, integrating various social features and aiming for significant user growth through substantial promotional investments [3] Gaming Performance - Tencent's gaming division is performing robustly, with a notable increase in overseas revenue, showcasing the company's strong competitive advantage and ability to adapt to market changes [4] Content Strategy - Tencent Video is adapting to market pressures by transitioning to an advertising-driven model while continuing to invest in high-quality content, aiming to leverage its large user base for enhanced revenue generation [5]

Investment Rating - The report assigns a positive investment rating to the company, highlighting its potential in the oncology sector with innovative drug candidates [7][36]. Core Insights - The company, 加科思, focuses on developing targeted therapies for cancer, particularly through its KRAS inhibitors and antibody-drug conjugates (ADCs) [4][8]. - The management team, led by founder Dr. Wang Yinxiang, has extensive experience in drug development, particularly in oncology [2][3]. - 加科思's lead product, 戈来雷塞 (Glecirasib), has been approved for the treatment of KRAS G12C mutation-positive non-small cell lung cancer (NSCLC) in China, marking a significant milestone for the company [10][37]. - The company is advancing multiple clinical trials, including JAB-23E73, a pan-KRAS inhibitor, which is expected to enter pivotal studies in 2026 [36][37]. Company Overview - 加科思 is headquartered in Beijing with additional offices in Shanghai and Boston, employing over 210 staff, primarily in preclinical and clinical development [3]. - The company has established a robust pipeline focusing on the KRAS signaling pathway, with several drug candidates targeting different nodes of this pathway [4][5]. Product Pipeline - The product pipeline includes: - JAB-3312 (SHP2 inhibitor) and Glecirasib (KRAS G12C inhibitor) for NSCLC [12]. - JAB-BX600, a tADC targeting KRAS G12D, which is designed to enhance drug delivery and efficacy [23][24]. - JAB-BX467, an iADC that aims to convert cold tumors into hot tumors by recruiting immune cells [27][28]. Clinical Data - Glecirasib has shown promising clinical results, with a 49.6% objective response rate (ORR) and an 86.3% disease control rate (DCR) in a pivotal study for 2L NSCLC [10][11]. - The combination of Glecirasib and JAB-3312 in first-line NSCLC treatment demonstrated a 71% ORR, significantly outperforming standard therapies [12][13]. Financial Performance - The company reported a 100% increase in revenue for the first half of 2025, driven by sales from Glecirasib and collaboration agreements [35]. - The company maintains a strong cash position, with 1.07 billion yuan in cash and available credit to support ongoing clinical development [35]. Strategic Partnerships - 加科思 has entered into strategic partnerships, including a collaboration with 阿斯利康 for JAB-23E73, which includes significant milestone payments and revenue sharing [37].

业绩再超预期，浆纸一体化驱动价值重构 玖龙纸业(2689) [Table_Industry] 林纸产品 | [Table_Invest] 评级： | 增持 | | --- | --- | | [当前价格 Table_CurPrice] (港元)： | 7.46 | [Table_Market] 交易数据 玖龙纸业公司更新报告 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 刘佳昆(分析师) | 021-38038184 | liujiakun@gtht.com | S0880524040004 | | 毛宇翔(分析师) | 021-38038672 | maoyuxiang@gtht.com | S0880524080013 | 本报告导读： 玖龙业绩再超预期，FY26H1 预计盈利 19.5-20.5 亿元，浆纸一体化驱动公司价值重 构 投资要点： | 财务摘要(百万元人民币) | FY2024A | FY2025A | FY2026E | FY2027E | FY2028E | | --- | --- | --- | - ...

Investment Rating - The investment rating for the company is "Accumulate" [5] Core Insights - The company has exceeded performance expectations, with FY26H1 projected earnings between 1.95 billion to 2.05 billion RMB, driven by the integration of pulp and paper operations [2][9] - The integration of pulp and paper production is expected to significantly enhance profitability, with major contributions from new capacities in Hubei and Beihai [9] - The company anticipates further price increases in short-fiber pulp and improvements in profitability for cultural and white card paper, which are currently at historical low levels [9] Financial Summary - Total revenue projections are as follows: - FY2024A: 59.50 billion RMB - FY2025A: 63.24 billion RMB - FY2026E: 69.30 billion RMB - FY2027E: 76.29 billion RMB - FY2028E: 84.02 billion RMB - Revenue growth rates are expected to be 4.9%, 6.3%, 9.6%, 10.1%, and 10.1% respectively [3][10] - Net profit projections are as follows: - FY2024A: 750.68 million RMB - FY2025A: 1.77 billion RMB - FY2026E: 4.00 billion RMB - FY2027E: 4.40 billion RMB - FY2028E: 4.84 billion RMB - Net profit growth rates are expected to be 131.5%, 135.4%, 126.6%, 9.8%, and 10.2% respectively [3][10] - The company’s PE ratio is projected to decrease from 20.31 in FY2024A to 7.23 in FY2028E, indicating increasing valuation attractiveness [3][10] Market Data - The current stock price is 7.46 HKD, with a market capitalization of 35.00 billion HKD and a 52-week price range of 2.82 to 7.46 HKD [6][10]

港股公司 证 券 研 究 报 告 太平洋航运（02343.HK）深度研究报告 推荐（首次） 经营稳健、穿越周期的小宗散运龙头船东， 有望受益于行业持续复苏 ❖ 风险提示：宏观经济下行、运力供给过剩、油价大幅波动等。 邮箱：wuchenyue@hcyjs.com 执业编号：S0360523070001 [主要财务指标 Indicator_FinchinaSimpleHK] | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业总收入(百万美元) | 2,582 | 2,336 | 2,369 | 2,423 | | 同比增速(%) | 12.4% | -9.5% | 1.4% | 2.3% | | 归母净利润(百万美元) | 132 | 98 | 156 | 217 | | 同比增速(%) | 20.4% | -25.2% | 58.8% | 39.0% | | 每股盈利(美元) | 0.03 | 0.02 | 0.03 | 0.04 | | 市盈率(倍) | 16 | 21 | 13 | 9 | | 市净率(倍) | 1 ...

Investment Rating - The investment rating for the company is "Buy" [7] Core Insights - The company has shown steady performance despite high base effects, with currency fluctuations potentially causing short-term profit disturbances. The expansion of Miu Miu continues in 2026, and the consolidation of Versace will contribute new revenue streams. The overall customer base remains stable, and the industry is entering a new normal [2][11]. Financial Summary - Total revenue is projected to reach €5,432 million in 2024, with a growth rate of 14.9%. By 2027, revenue is expected to increase to €6,640 million, maintaining a growth rate of 7.8% [4]. - Gross profit is forecasted to be €4,337 million in 2024, increasing to €5,325 million by 2027, with a consistent gross margin around 80% [4][15]. - Net profit attributable to shareholders is expected to grow from €839 million in 2024 to €1,046 million in 2027, reflecting a growth rate of 25.0% in 2024 and around 9.0% in 2027 [4][15]. Market Outlook - The company anticipates a retail sales growth of approximately high single digits for the full year 2025 at constant exchange rates, leading the industry. The retail growth for Q4 2025 is expected to be in the mid-single digits, slightly slowing from Q3 [11]. - Miu Miu is projected to contribute an additional 10%-15% in retail space, focusing on the Eurasian region, with plans to expand into the low-penetration U.S. market by 2027 [11]. - The luxury goods industry is shifting from rapid growth to a "new normal," characterized by market share consolidation among strong brand DNA companies [11].

Investment Rating - The report maintains an "Outperform" rating for Sands China [2][16]. Core Insights - The company achieved net revenue of USD 2.058 billion in Q4 2025, representing a year-over-year increase of 16.2%. Adjusted property EBITDA reached USD 608 million, up 6.5% year-over-year, with an adjusted property EBITDA margin of 29.5% [4][12]. - The performance of the company's properties varied, with The Venetian and Plaza showing net revenue increases both year-over-year and quarter-over-quarter, while The Parisian and Sands underperformed [13][14]. - The company's gaming gross revenue increased significantly to USD 2.02 billion, up 23.1% year-over-year, driven by growth in VIP and premium mass segments [5][14]. - The adjusted EBITDA margin declined to 29.5%, down 2.7 percentage points year-over-year, primarily due to a shift in business structure and rising operating costs [6][15]. - The company's market share improved to 24.4% in Q3 2025, up from 23.7% in Q3 2024, indicating a positive trend in competitive positioning [7]. Financial Projections - For FY 2026 and 2027, net revenue is projected to be USD 7.937 billion and USD 8.363 billion, respectively, with gaming gross revenue expected to reach USD 7.652 billion and USD 8.082 billion [16]. - The adjusted property EBITDA is forecasted to be USD 2.483 billion in 2026 and USD 2.643 billion in 2027, with corresponding adjusted property EBITDA margins of 31.3% and 31.6% [16].

港股公司 证 券 研 究 报 告 太平洋航运（02343.HK）深度研究报告 推荐（首次） 经营稳健、穿越周期的小宗散运龙头船东， 有望受益于行业持续复苏 ❖ 风险提示：宏观经济下行、运力供给过剩、油价大幅波动等。 [主要财务指标 Indicator_FinchinaSimpleHK] 航运 2026 年 01 月 29 日 目标价：3.70 港元 当前价：3.12 港元 华创证券研究所 证券分析师：吴一凡 邮箱：wuyifan@hcyjs.com 执业编号：S0360516090002 证券分析师：吴晨玥 邮箱：wuchenyue@hcyjs.com 执业编号：S0360523070001 证券分析师：卢浩敏 邮箱：luhaomin@hcyjs.com 执业编号：S0360524090001 | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业总收入(百万美元) | 2,582 | 2,336 | 2,369 | 2,423 | | 同比增速(%) | 12.4% | -9.5% | 1.4% | 2.3% | | ...

研究报告 Research Report 29 Jan 2026 新东方-S New Oriental (9901 HK) 超预期并上调指引；降本增效战略持续显效 Beat and Raise guidance; efficiency improvement strategy is yielding results [Table_yemei1] 观点聚焦 Investment Focus [Table_Info] 维持优于大市 Maintain OUTPERFORM 评级 优于大市 OUTPERFORM 现价 HK$46.04 目标价 HK$52.00 HTI ESG 5.0-5.0-5.0 E-S-G: 0-5, (Please refer to the Appendix for ESG comments) 市值 HK$75.29bn / US$9.65bn 日交易额 (3 个月均值) US$19.47mn 发行股票数目 1,635mn 自由流通股 (%) 88% 1 年股价最高最低值 HK$47.24-HK$32.85 注：现价 HK$46.04 为 2026 年 01 月 29 日收盘价 资料来源： F ...

证券研究报告|港股公司点评报告 出国教育业务增速分化，核心板块展现增长韧性。1）FY26Q2 海外考试准备和出国咨询业务同比变化分别为 +4.1%/-3.0%（FY26Q1 为 1.0%及 2.0%）。2）大学生及成人考试业务同比增长 12.8%（FY26Q1 为 14.4%）。 FY2026Q2 归母净利率提升幅度低于毛利率，主要由于其他收入占比下降、公允价值变动收益转负，部分抵 消 了 费 用率优化的正向影响。（1）FY2026Q2 公司毛利率/归母净利率分别为 53.3%/3.8%，同比提升 1.2/0.7PCT。（2）从费用率来看，FY2026Q2 销售/管理费用率分别为 16.3%/31.4%，同比下降 2.6/0.1PCT；公允 价值变动收益占比下降 0.4PCT（由正转负）；其他收入占比下降 1.1PCT；所得税拨备占比增加 0.6PCT。 [Table_Date] 2026 年 01 月 29 日 [Table_Title] Q2 业绩超预期，教育业务稳健增长 [Table_Title2] 新东方-S(9901.HK) | [Table_DataInfo] 评级： | 买入 | 股票代码： | ...